Ecotoxicology – Toxicant Chemistry, Metabolism & Mechanisms

Chemical Nature of Toxicants

• Impossible to define a single set of chemical characteristics for toxicity because toxicants interact with biological systems in many different ways.

• Small changes in chemistry/biochemistry → large changes in toxic response. Example:

  • Carbon tetrachloride $( ext{CCl}_4)$: highly toxic (esp. chronic liver injury).

  • Dichlorodifluoromethane $( ext{CCl}<em>2 ext{F}</em>2)$: essentially nontoxic except as asphyxiant/lung irritant at high levels.

• Toxicological chemistry = chemistry of toxic substances with emphasis on interactions with biomolecules.

• Quantitative Structure–Activity Relationships (QSAR)

  • Correlate chemical structure & physical properties with toxicity via mathematical models.

  • Aid prediction of toxicity of new compounds/classes.

• Impact of functional groups on LD50 (oral, rat) of substituted benzenes (color scale diagram):

  • Most toxic: aniline (red, $-\text{NH}_2$).

  • Least toxic: meta- & para-xylene (green, $-\text{CH}_3$ groups only).

• Five broad chemical categories of toxicants:

  1. Extremes of acidity/basicity/dehydration/oxidizing power (e.g., conc. $\text{H}<em>2\text{SO}</em>4$, $\text{NaOH}$, elemental $\text{F}_2$) → non-kinetic poisons/corrosives; act at site of contact.

  2. Reactive functional groups are able to attack biomolecules.

  • Diethyl ether $(\text{C}<em>2\text{H}</em>5!−!\text{O}−!\text{C}<em>2\text{H}</em>5)$ relatively nontoxic (stable C–H & C–O–C bonds).

  • Allyl alcohol (reactive alkenyl group) toxic irritant; LD50 ~100× lower (more toxic) than 1-propanol (propyl alcohol).

  1. Heavy metals: bind to enzymes, especially thiol $(-\text{SH})$ groups.

  2. Binding species: toxic via reversible or irreversible binding to biomolecules.

  • Reversible: $\text{CO}$ + hemoglobin → carboxyhemoglobin, blocks $\text{O}_2$ transport.

  • Irreversible: Electrophilic carbonium ion $\text{H}_3\text{C}^+$ binding to nucleophilic N on guanine of DNA.

  1. Lipid-soluble compounds: cross membranes easily; bio-uptake/biomagnification.

  • Order of permeability across phospholipid bilayer: gases > hydrophobic mol. > small polar > large polar > ions.

Fate of Xenobiotics in the Body

• Possible pathways: absorption → metabolism → temporary storage → distribution → excretion.

• Ultimate outcomes for most xenobiotics: metabolic inactivation or direct excretion.

• Some need metabolic activation (protoxicants → toxic metabolites).

• Enzymes normally handle endogenous substrates but also act on xenobiotics.

  • Example: flavin-containing monooxygenase converts cysteamine → cystamine & oxidizes N/S xenobiotics.

• Non-enzymatic reactions also occur (direct bonding, hydrolysis, redox).

• Likelihood of enzymatic metabolism depends on physicochemical traits:

  • Water-soluble: usually excreted unchanged.

  • Volatile: exhaled rapidly.

  • Nonpolar lipophilic: prime candidates; if resistant (e.g., PCBs) → bioaccumulate.

Phase I Reactions (Functionalization)

• Add or expose polar “handles” → ↑water solubility; introduce sites for Phase II conjugation.

• Major types:

1. Oxidations (most important)

   • Monooxygenation (mixed-function oxidase): $\text{RH}+\text{O}<em>2+\text{NADPH}+\text{H}^+→\text{ROH}+\text{H}</em>2\text{O}+\text{NADP}^+$.

   • Catalyzed mainly by cytochrome P-450 (Fe cycles $+2/ +3$).

   • Epoxidation: inserts O between two C atoms in unsat. system; key for aromatic rings.

   • Often increases toxicity (bioactivation).

2. Hydroxylation

   • Add $-\text{OH}$ to aliphatic or aromatic C; ω or ω-1 positions on alkanes.

   • Can follow epoxidation.

3. Epoxide Hydration

   • Add $\text{H}_2\text{O}$ to epoxide → dihydrodiol (often detoxication, but some dihydrodiols may be re-epoxidized to more reactive/carcinogenic forms).

4. Oxidation of N, S, P (non-C)

   • Example: 2-acetylaminofluorene → $N$-hydroxy metabolite (potent carcinogen).

   • Parathion $\xrightarrow[\text{cyt P-450}]{\text{desulfuration}}$ paraoxon (stronger acetylcholinesterase inhibitor).

   • Catalyzed also by flavin-containing monooxygenase.

5. Alcohol Dehydrogenation

   • Primary alcohol $\rightarrow$ aldehyde; secondary $\rightarrow$ ketone.

   • Aldehyde $\rightarrow$ carboxylic acid (detoxication: ↑water solubility).

6. Reductions (nitroreductase, others)

   • Mostly by anaerobic gut flora; e.g., $\text{NO}_2$ group reductions; sulfone/sulfoxide $\rightarrow$ sulfide.

7. Hydrolysis (hydrolases)

   • Esters (esterases) & amides (amidases) → cleavage products; toxicity may ↑ or ↓.

   • Important for many pesticides, organophosphates.

8. Dealkylation (mixed-function oxidase)

   • Replace alkyl (e.g., $-\text{CH}_3$) on O, N, S with H.

9. Dehalogenation

   • Reductive: halogen $\rightarrow$ H or elimination → $\text{C}=\text{C}$.

   • Oxidative: O inserted in place of halogen.

Phase II Reactions (Conjugation)

• Join xenobiotic (often Phase I product) with endogenous conjugating agent; usually rapid.

• Product: ↑polarity, ↑water solubility, ↓toxicity, ↑excretion.

• Functional groups on xenobiotic that react: carboxyl ($-\text{COOH}$), hydroxyl ($-\text{OH}$), amino ($+\text{NH}_3$), halogens, epoxides, etc.

• Main conjugation types & agents:

1. Glucuronidation

   • Agent: UDP-glucuronic acid; enzyme: glucuronyl transferase (ER-bound).

   • Forms ether or ester glucuronides (O-, N-, S- linked); low-MW conjugates → urine.

2. Glutathione (GSH) Conjugation

   • GSH = Glu-Cys-Gly tripeptide.

   • Enzyme: glutathione transferase.

   • $-\text{SH}$ loses $\text{H}^+$ → $\text{S}^-$ nucleophile attacks electrophiles (alkenes, epoxides, halides, nitro aromatics).

   • Conjugate often processed → mercapturic acids (acetylated Cys moiety) before excretion.

   • Key detoxication pathway protecting nucleic acids/proteins from electrophiles.

3. Sulfation

   • Agent: activated sulfate (3′-phosphoadenosine-5′-phosphosulfate, PAPS); enzyme: sulfotransferase.

   • Substrates: alcohols, phenols, aryl amines.

   • Highly water-soluble conjugates → urine; can bioactivate (e.g., safrole sulfate → carbonium ion → DNA adducts → tumors).

4. Acetylation

   • Agent: acetyl-CoA; enzyme: acetyltransferase.

   • Important for aromatic amines; converts ionizable $-\text{NH}<em>2$ to non-ionizable $-\text{NHCOCH}</em>3$, sometimes ↓water solubility.

   • Final step in mercapturic acid formation.

5. Methylation

   • Agent: S-adenosylmethionine (SAM); adds $+\text{CH}_3$ (electrophilic carbocation).

   • Substrates: nucleophilic O, N, S (amines, heterocycles, phenols, thiols). Example: nicotine $\rightarrow$ N-methylnicotinium ion.

   • Often ↓hydrophilicity (unique among Phase II paths).

6. Amino-acid Conjugation

   • Agents: glycine, glutamine, taurine, serine, or dipeptides.

   • Example: benzoic acid + glycine $\rightarrow$ hippuric acid (1842 discovery).

Biochemical Mechanisms of Toxicity

Toxicant–Receptor Interactions

• Receptor = macromolecule (protein, nucleic acid, membrane lipid) that binds ligand → effect.

• Ligand may be xenobiotic or endogenous.

• Interaction highly specific (lock-and-key stereochemistry).

• Binding ~100× stronger than enzyme–substrate; receptor not chemically altered.

• Possible outcomes:

  • Agonist/activator: toxicant activates receptor → exaggerated/aberrant effect.

  • Antagonist: toxicant occupies site, blocks endogenous ligand.

  • Allosteric interference: binds nearby site, disturbs normal binding.

Interference with Enzyme Action

• Enzymes = essential catalysts; inhibition → toxicity.

• Mechanisms:

  1. Direct inhibition by heavy-metal ions (Hg$^{2+}$, Pb$^{2+}$, Cd$^{2+}$)

  • Strong affinity for sulfur functional groups ($-\text{SS}-$, $-\text{SH}$, $-\text{SCH}_3$) at enzyme active sites.

  • Binding blocks substrate access → loss of catalytic activity.

  1. Metal substitution in metalloenzymes

  • Cd$^{2+}$ replaces Zn$^{2+}$ due to chemical similarity but fails to perform biochemical function → toxicity.

  1. Covalent inhibition by organic xenobiotics

  • Example: organophosphate nerve agent diisopropylphosphorfluoridate binds hydroxyl of serine in acetylcholinesterase active site → enzyme inactivation.

• Enzyme induction: body up-regulates enzymes to metabolize specific xenobiotics (adaptive but can produce tolerance or reactive intermediates).

Key Equations & Numerical References

• $\text{Cytochrome P-450 monooxygenation: } \text{RH}+\text{O}<em>2+\text{NADPH}+\text{H}^+→\text{ROH}+\text{H}</em>2\text{O}+\text{NADP}^+$

• $\text{Epoxidation: } \text{RCH}=\text{CH}<em>2 + [\text{O}] → \text{RCH(O)}\text{CH}</em>2$ (epoxide ring)

• $\text{Allyl alcohol LD}_{50} \approx 100 \times \text{higher toxicity than 1-propanol}$

• Heavy-metal binding example: $\text{Enzyme-SH} + \text{Hg}^{2+} → \text{Enzyme-S-Hg}^{+} + \text{H}^+$

• Safrole bioactivation: safrole $\xrightarrow{\text{sulfation}}$ safrole sulfate $\xrightarrow{\text{loss of SO}_3^{2-}}$ carbonium ion $\rightarrow$ DNA adduct.

Practical & Ethical Implications

• QSAR & mechanistic understanding enable prediction and mitigation of chemical hazards before widespread exposure.

• Bioaccumulative lipophilic pollutants (e.g., PCBs) require special regulatory focus due to persistence & trophic magnification.

• Phase I bioactivation can turn innocuous compounds into carcinogens (e.g., benzo(a)pyrene, parathion) highlighting need for metabolic studies in risk assessment.

• Enzyme inhibition by heavy metals underscores importance of environmental controls for industrial emissions and remediation of contaminated sites.

• Understanding receptor binding aids antidote design (e.g., oxygen therapy for CO poisoning, atropine for organophosphate exposure).